Treatment of HIV-associated invasive anal cancer with combined chemoradiation

European Journal of Cancer

Volumn 36, Issue 6, 2000, Pages 754-758

  Cleator, S ^a   Fife, K ^a,b   Nelson, M ^b   Gazzard, B ^b   Phillips, R ^a   Bower, M ^b  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

AIDS; Anal cancer; Chemoradiation; HIV

Indexed keywords

FLUOROURACIL; MITOMYCIN C;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANUS CARCINOMA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLOSTOMY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG TOXICITY; GASTROINTESTINAL SYMPTOM; HEMATOLOGIC DISEASE; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANUS NEOPLASMS; COMBINED MODALITY THERAPY; FLUOROURACIL; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM INVASIVENESS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0034114646     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00009-5     Document Type: Article

References (26)

1. Melbye M., Cote T.R., Kessler L., Gail M., Biggar R.J. AIDS/Cancer Working Group High Incidence of anal cancer among AIDS patients. Lancet. 343:1994;636-639.
2. Frisch M., Melbye M., Moller H. Trends in incidence of anal cancer in Denmark. Br. Med. J. 306:1993;419-422.
3. Palefsky J.M., Holly E.A., Ralston M.et al. High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men. AIDS. 12:1998;495-503.
4. Palefsky J.M., Holly E.A., Gonzales J., Berline J., Ahn D.K., Greenspan J.S. Detection of human papillomavirus DNA in anal intraepithelial neoplasia and anal cancer. Cancer Res. 51:1991;1014-1019.
5. Palefsky J.M., Holly E.A., Ralston M.L., Darragh T., Jay N., Berry M. The effect of HAART on the natural history of anal squamous intraepithelial lesion in HIV+ men. JAIDS. 21:1999;A13.
6. Nigro N.D., Vaitkevicius V.K., Considine B. Combined therapy for cancer of the anal canal. A preliminary report. Dis. Colon. Rectum. 17:1974;354-356.
7. Cummings B.J. Anal Cancer. Int. J. Radiation Oncology Biol. Phys. 19:1990;1309-1315.
8. UKCCCR Anal Cancer Trial Working Group Epidermoid anal cancer. results from the UKCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin Lancet. 348:1996;1049-1054.
9. Bartelink H., Roelofsen F., Eschwege F.et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer. results of a phase III randomised trial of the European Radiotherapy and Gastrointestinal Cooperative Groups J. Clin. Oncol. 15:1997;2040-2049.
10. Lorenz H.P., Wilson W., Leigh B., Crombleholme T., Schecter W. Squamous cell carcinoma of the anus and HIV infection. Dis. Colon. Rectum. 34:1991;336-338.
11. Svensson C., Kaigas M., Lidbrink E., Goldman S. Carcinoma of the anal canal in a patient with AIDS. Acta Oncol. 30:1991;986-987.
12. Peddada A.V., Smith D.E., Rao A.R., Frost D.B., Kagan A.R. Chemotherapy and Low-dose radiotherapy in the treatment of HIV-infected patients with carcinoma of the anal canal. Int. J. Radiation Oncology Biol. Phys. 37:1997;1101-1105.
13. Cox J.D., Stetz J.B.S., Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int. J. Radiation Oncology Biol. Phys. 31:1995;1341-1346.
14. Kaplan E., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:1958;457-481.
15. Peto R., Pike M., Armitage P.et al. Design and analysis of randomised clinical trials requiring prolonged observation of each patient II. analysis and examples Br. J. Cancer. 35:1977;1-39.
16. Sartovelli A.C. Therapeutic attack of hypoxic cells of solid tumours. Cancer Res. 48:1988;775-778.
17. Sischy B., Doggett R.L.S., Krall J.M.et al. Definitive irradiation and chemotherapy for radiosensitization in management of anal carcinoma. interim report on Radiation Therapy Oncology Group Study No. 8314 J. Natl. Cancer Inst. 81:1989;850-856.
18. Watkins E.B., Findlay P., Geldmann E., Lane H.C., Zabell A. Enhanced mucosal reactions in AIDS patients receiving oropharyngeal irradiation. Int. J. Radiation Oncology Biol. Phys. 13:1987;1403-1408.
19. Chadha M., Rosenblatt E.A., Malamud S., Pisch J., Berson A. Squamous-cell carcinoma of the anus in HIV-positive patients. Dis. Colon. Rectum. 37:1994;861-865.
20. Holland J.M., Swift P.S. Tolerance of patients with human immunodeficiency virus and anal carcinoma to treatment with combined chemotherapy and radiation treatment. Radiology. 193:1994;251-254.
21. Hoffman R., Welton M.L., Klencke B., Weinberg V., Kreig R. The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer. Int. J. Radiat. Oncol. Biol. Phys. 44:1999;127-131.
22. Cummings B.J., Keane T.J., O'Sullivan B., Wong C.S., Catton C.N. Epidermoid anal cancer. treatment by radiation alone or by radiation and 5- fluorouracil with and without mitomycin C Int. J. Radiation Oncology Biol. Phys. 25:1991;1115-1125.
23. Flam M., John M., Pajak T.F.et al. role of mitomycin in combination with fluorouracil and radiotherapy, and salvage chemoradiation in the definitive treatment of epidermoid carcinoma of the anal canal. results of a phase III randomized intergroup study J. Clin. Oncol. 14:1996;2527-2539.
24. Nigro N.D., Vaitkevicius V.K. Combined therapy for cancer of the anal canal. Dis. Colon. Rectum. 34:1991;482-486.
25. Golden G.T., Horsely J.S. Surgical management of epidermoid carcinoma of the anus. Am. J. Surg. 131:1976;275-280.
26. Newman G., Calverley D.C., Acker B.D., Manji M., Hay J., Flores A.D. The management of carcinoma of the anal canal by external beam radiotherapy, experience in Vancouver 1971-1988. Radiotherapy and Oncology. 25:1992;196-202.